Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q10 deficiency harboring a heterozygous mutation in COQ4 gene

Stem Cell Res. 2017 Oct:24:144-147. doi: 10.1016/j.scr.2016.09.007. Epub 2016 Sep 16.

Abstract

We report the generation, CRISPR/Cas9-edition and characterization of induced pluripotent stem cell (iPSC) lines from a patient with coenzyme Q10 deficiency harboring the heterozygous mutation c.483G>C in the COQ4 gene. iPSCs were generated using non-integrative Sendai Viruses containing the reprogramming factors OCT4, SOX2, KLF4 and C-MYC. The iPSC lines carried the c.483G>C COQ4 mutation, silenced the OKSM expression and were mycoplasma-free. They were bona fide pluripotent cells as characterized by morphology, immunophenotype/gene expression for pluripotent-associated markers/genes, NANOG and OCT4 promoter demethylation, karyotype and teratoma formation. The COQ4 mutation was CRISPR/Cas9 edited resulting in isogenic, diploid and off-target free COQ4-corrected iPSCs.

Publication types

  • Case Reports

MeSH terms

  • Cell Differentiation
  • Child, Preschool
  • Female
  • Genomics / methods*
  • Heterozygote
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Kruppel-Like Factor 4
  • Mitochondrial Proteins / genetics*
  • Mitochondrial Proteins / metabolism
  • Mutation
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / deficiency

Substances

  • COQ4 protein, human
  • KLF4 protein, human
  • Kruppel-Like Factor 4
  • Mitochondrial Proteins
  • Ubiquinone
  • coenzyme Q10